Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Research Reports

What is the Regulatory Impact on Centrifugal Blood Pumps Sales?

Published by linker 5

Posted on February 2, 2021

Featured image for article about Research Reports

Key market players are aiming at strategic alliances with service providers to address the requirements of an expanding patient base.

FMI states in its recent study that the centrifugal blood pump market will record a CAGR of 4% through 2030. Demand for centrifugal blood pumps is anticipated to continue surging particularly due to the increase in heart diseases of people all across the world.

“A slew of cardiovascular products was launched for the management of cardiac disorders over the last decade and development of more are currently underway. With leading manufacturers expecting the demand to surge amid COVID-19, centrifugal blood pump sales are set to grow steadily through 2030.” says the FMI analyst.

Request a report sample to gain comprehensive market insights at https://www.futuremarketinsights.com/reports/centrifugal-blood-pump-market

Centrifugal blood pump Market – Important Highlights

The demand for electronic centrifugal blood pumps is estimated to rise in the forecasted period, owing to its increased energy efficiency
Hospital sectors are anticipated to be the leading end-users
North America led by the US is estimated to be the major shareholder in the market owing to its expansion in healthcare spending.
China is estimated to be the lead market for centrifugal blood pumps in the forecasted period, due to its rapid increase in the geriatric population

Centrifugal blood pump Market – Drivers

The rapid increase in health problems like heart diseases around the world
Increasing in geriatric population
Favorable government policies like an increase in healthcare spending are further driving the market.

Centrifugal blood pump Market – Restraints

Low-cost alternatives by China-based pump manufacturers is expected to be a hurdle in the growth of the global centrifugal pump market during the forecast period

A low rate of energy-efficiency is expected to restrain the growth of global centrifugal pump market growth over the period.

For any Queries Linked with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-6451

COVID-19 Impact on Centrifugal blood pump Market

During this time there has been a disruption in the supply and demand chain which has caused an impact on the revenue of the centrifugal blood pumps in a negative way. However, this is estimated to be a temporary effect and the market is expected to have a turnaround. The pandemic has led to a decrease in the patient’s flow in the hospitals, and doctor chambers. This has caused a reduction in the number of cardio surgeries and that in turn has affected the centrifugal blood pumps market.

Competitive Landscape

Key market players are aiming at strategic alliances with service providers to address the requirements of an expanding patient base.

For example, In Feb 2018, LivaNova PLC agreed to acquire TandemLife, a privately held company that was focused on advanced cardiopulmonary temporary support solutions. Some of the leading companies operating in the centrifugal blood pump market are Medtronic Plc, Thoratec Corporation (Abbott), Terumo Corporation, and so on.